Is IMGN A Good Stock To Buy Now?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter,...
Posts Tagged ‘NASDAQ:IMGN’
Hedge Funds Are Dipping Their Toes Into ImmunoGen, Inc. (IMGN)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (...
Did Hedge Funds Make The Right Call On ImmunoGen, Inc. (IMGN) ?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings...
Hedge Funds Have Never Been This Bullish On ImmunoGen, Inc. (IMGN)
In this article we will check out the progression of hedge fund sentiment towards ImmunoGen, Inc. (NASDAQ:IMGN) and determine whether it is a good investment...
Hedge Funds Are Dumping ImmunoGen, Inc. (IMGN)
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November. Among them, Facebook...
Is ImmunoGen, Inc. (IMGN) A Good Stock To Buy?
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the...
Here’s What Hedge Funds Think About ImmunoGen, Inc. (IMGN)
Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by nearly 9 percentage points since the end of the third quarter of 2018 as investors worried...
Is ImmunoGen, Inc. (IMGN) A Good Stock To Buy?
The elite funds run by legendary investors such as David Tepper and Dan Loeb make hundreds of millions of dollars for themselves and their investors by...
Hedge Fund and Insider Trading News: Steve Eisman, Carl Icahn, Voce Capital, New Residential Investment Corp (NRZ), ImmunoGen, Inc. (IMGN), and More
Column: Hedge Funds Bet Cautiously on Even Higher Oil Prices (Reuters) LONDON (Reuters) – Hedge funds added more bullish positions in crude and...
Hedge Funds Are Betting On ImmunoGen, Inc. (IMGN)
Insider Monkey has processed numerous 13F filings of hedge funds and famous investors to create an extensive database of hedge fund holdings. The 13F...
Hedge Fund and Insider Trading News: Steven A. Cohen, Citadel, Apollo Global Management LLC (APO), New Peoples Bankshares (NWPP), Lennox International (LII), and More
Steven Cohen Wins Dismissal of $8 billion Fairfax Short-selling Lawsuit (Reuters) (Reuters) – The billionaire Steven A. Cohen has won the dismissal...
Hedge Fund and Insider Trading News: T. Boone Pickens, Steve Eisman, ImmunoGen, Inc. (IMGN), Motus GI Holdings Inc (MOTS), VerifyMe Inc (VRME), and More
Trading ‘BOON’ Pickens: Oil Tycoon’s Spinoff Fund Seeks Listing (Bloomberg) Legendary oil tycoon T. Boone Pickens has closed his hedge fund,...
Market Movers Today: Electronic Arts Inc. (EA), ImmunoGen, Inc. (IMGN), Juniper Networks, Inc. (JNPR), and More
Electronic Arts Inc. (NASDAQ:EA) (MarketWatch) The poor performance of Electronic Arts Inc.’s “Star Wars Battlefront 2” was in the spotlight on...
Wondering What’s Happening in the Financial Markets Today? Take a Look at These 34 Stories!
1. U.S. Stock Market: “Stocks rose on Wall Street on Thursday, capping a wave of declines in major world equity markets triggered by uncertainty...
32 Major Stories Summarizing What’s Happening in the World of Finance Today
1. U.S. Stock Market: “The S&P 500 and the Nasdaq Composite hit fresh intraday records on Monday as a jump in oil prices to a two-week high...
This Is What You Should Know About The Financial Markets Today
1. US Stock Market: “U.S. equities traded mixed on Wednesday, with IBM sending the Dow Jones industrial average lower and Morgan Stanley leading...
Here’s What You Need To Know About The Financial Markets Today
1. US Stock Market: “Stocks fell on Thursday after the U.S. dropped “the mother of all bombs” in Afghanistan while bank stocks dropped...
Hedge Funds Are Selling ImmunoGen, Inc. (IMGN)
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment...
Here’s why Microsoft, ImmunoGen, and Three Other Stocks Are Trending on Tuesday
The three major index futures and crude are once again in the red on Tuesday amid Brexit fears. If Britain leaves the EU, there could be an unexpected...
Here is What Hedge Funds Think About ImmunoGen, Inc. (IMGN)
The elite funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by...
What’s the Deal With These Four Sinking Stocks?
ImmunoGen Inc. (NASDAQ:IMGN), Vipshop Holdings Limited (NYSE:VIPS), Urban Outfitters Inc. (NASDAQ:URBN), and TerraForm Power Inc. (NASDAQ:TERP) ...
Nektar Therapeutics (NKTR): Insiders Aren’t Crazy About It But Hedge Funds Love It
Is Nektar Therapeutics (NASDAQ:NKTR) a good investment? Now, according to many of your peers, hedge funds are assumed to be useless, outdated investment...
Acorda Therapeutics Inc (ACOR): Insiders Aren’t Crazy About It But Hedge Funds Love It
To many investors, hedge funds are assumed to be bloated, outdated investment tools of a forgotten age. Although there are In excess of 8,000 hedge funds...
Viropharma Inc (VPHM): Are Hedge Funds Right About This Stock?
Is Viropharma Inc (NASDAQ:VPHM) a good investment? If you were to ask many traders, hedge funds are seen as useless, old investment vehicles of an era...
Alnylam Pharmaceuticals, Inc. (ALNY): Insiders Aren’t Crazy About It But Hedge Funds Love It
Who’s crazy about Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)? If you were to ask many market players, hedge funds are seen as useless, outdated...
Alnylam Pharmaceuticals, Inc. (ALNY): Here’s What The Smart Money Thinks
Is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) the right investment to pursue these days? Hedge funds are taking a bullish view. The number of bullish...
Seattle Genetics, Inc. (SGEN), Celldex Therapeutics, Inc. (CLDX): This Company Has Potential to Grow
Cancer is the target of a number of different biotech companies. Out of this lot, I consider Seattle Genetics, Inc. (NASDAQ:SGEN) to be one of the star...
Immunomedics, Inc. (IMMU), ImmunoGen, Inc. (IMGN): Should You Invest in These Cancer Treatment Biotechs?
Today, cancer is the second leading cause of death in the United States, accounting for nearly a quarter of all deaths in the country. 1.7 million new...
Seattle Genetics, Inc. (SGEN): A Billion-Dollar Anticancer Technology in the Making
Anticancer drugs typically damage normal cells as well as cancer cells. Using a breakthrough technology, a midsize biotech company is developing a process...
ImmunoGen, Inc. (IMGN), Seattle Genetics, Inc. (SGEN), Celldex Therapeutics, Inc. (CLDX): A Trio of Cancer Immunotherapy Innovators
The cancer world has been abuzz after an exciting ASCO conference. Bristol Myers Squibb Co. (NYSE:BMY) presented really promising updates for its PD-...
Is Nektar Therapeutics (NKTR) Going to Burn These Hedge Funds?
Nektar Therapeutics (NASDAQ:NKTR) was in 8 hedge funds’ portfolio at the end of March. NKTR has experienced a decrease in support from the world...
Synta Pharmaceuticals Corp. (SNTA), VeriFone Systems Inc (PAY): 5 of Last Week’s Biggest Losers
There’s never a shortage of losers in the stock market. Let’s take a closer look at five of this past week’s biggest sinkers. Company...
This Metric Says You Are Smart to Sell ImmunoGen, Inc. (IMGN)
Is ImmunoGen, Inc. (NASDAQ:IMGN) an excellent investment now? Prominent investors are in a bearish mood. The number of bullish hedge fund bets stayed...
ImmunoGen, Inc. (IMGN), AEterna Zentaris Inc. (USA) (AEZS) – Tackling Cancer: Your Best Investing Ideas
Over the past three months, we’ve taken a deep dive into the 12 cancer types most likely to be diagnosed in the U.S. this year according to the...
Myriad Genetics, Inc. (MYGN), Roche Holding Ltd. (ROG): Angelina Jolie’s Selfless Act Heightens Breast Cancer Awareness
I admit to not being a big fan of many of her movies — possibly the only man on the planet who will admit so — but there’s little denying...
Hedge Funds Are Selling ImmunoGen, Inc. (IMGN)
ImmunoGen, Inc. (NASDAQ:IMGN) investors should pay attention to a decrease in hedge fund interest recently. At the moment, there are dozens of methods...
Sarepta Therapeutics Inc (SRPT): FDA Says, “Call Me Maybe”
A lot has been written this week — at The Fool and elsewhere — about Sarepta Therapeutics Inc (NASDAQ:SRPT)‘ update on its meeting...
Acorda Therapeutics Inc (ACOR): Insiders Are Dumping, Should You?
Acorda Therapeutics Inc (NASDAQ:ACOR) was in 10 hedge funds’ portfolio at the end of the fourth quarter of 2012. ACOR investors should pay attention...
Pfizer Inc. (PFE) & More…a ‘Breakthrough’ May Be on the Way for Breast Cancer Patients
The process of developing a drug from start to finish is incredibly arduous, usually involves around $1 billion in costs, and can take upwards of a decade...
Tackling Cancer: Breast Cancer’s Biggest Current & Upcoming Players – Roche Holding Ltd. (ADR) (RHHBY), AstraZeneca plc (ADR) (AZN), ImmunoGen, Inc. (IMGN)
As I noted two weeks ago, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing...
This FDA Approval Is Actually a Big Deal: Dendreon Corporation (DNDN)
As we’ve learned in recent years, getting an approval from the Food and Drug Administration is only half the battle. Successfully commercializing...
This Week in Biotech: VIVUS, Inc. (VVUS), Roche Holdings Ltd-Spons Adr (RHHBY)
With the SPDR S&P Biotech Index up 25% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the...
